Skip Navigation

Journal of Biochemistry 2005 137(6):711-720; doi:10.1093/jb/mvi088
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Qu, X.
Right arrow Articles by Sada, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qu, X.
Right arrow Articles by Sada, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 The Japanese Biochemical Society

Regular Paper

Selective Inhibition of Fc{varepsilon}RI-Mediated Mast Cell Activation by a Truncated Variant of Cbl-b Related to the Rat Model of Type 1 Diabetes Mellitus

Xiujuan Qu1, S. M. Shahjahan Miah1, Tomoko Hatani1, Mami Okazaki1,*, Naoko Hori-Tamura1,*, Hirohei Yamamura1, Hak Hotta2 and Kiyonao Sada2,{dagger}

1 Division of Proteomics and 2 Division of Microbiology, Department of Genome Sciences, Kobe University Graduate School of Medicine, Kobe 650-0017

{dagger} To whom correspondence should be addressed. Phone: +81-78-382-5501, Fax: +81-78-382-5519, E-mail: ksada{at}med.kobe-u.ac.jp

Ubiquitin-protein ligase Cbl-b negatively regulates high affinity IgE receptor (Fc{varepsilon}RI)–mediated degranulation and cytokine gene transcription in mast cells. In this study, we have examined the role of a truncated variant of Cbl-b related to the rat model of type 1 diabetes mellitus using the mast cell signaling model. Overexpression of the truncated Cbl-b that lacks the C-terminal region did not suppress the activation of proximal and distal signaling molecules leading to degranulation. Fc{varepsilon}RI-mediated tyrosine phosphorylation of Syk, Gab2, and phospholipase C-{gamma}1, and activation of c-Jun N-terminal kinase (JNK), extracellular signal–regulated kinase (ERK), p38 mitogen–activated protein kinase (MAP kinase), and inhibitor of nuclear factor {kappa}B kinase (IKK), and generation of Rac1 are unaffected in cells overexpressing the truncated Cbl-b in the lipid raft. On the other hand, Fc{varepsilon}RI-mediated transcriptional activation of nuclear factor of activated T cells (NFAT), and transcription of interleukin-3 (IL-3) and IL-4 mRNA are inhibited by overexpression of the truncated variant of Cbl-b. This suppression parallels the re-compartmentalization of specific effector molecules in the lipid raft. These structural and functional analyses reveal the mechanism underlying the selective inhibition of cellular signaling by the truncated variant of Cbl-b related to insulin-dependent diabetes mellitus.

* On leave from the Registered Dietitian’s Section, Faculty of Home Economics, Kobe Women’s University.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
J. Cuschieri, J. Billigren, and R. V. Maier
Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: a condition reversed by PKC activation
J. Leukoc. Biol., December 1, 2006; 80(6): 1289 - 1297.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. E. Gustin, C. B. F. Thien, and W. Y. Langdon
Cbl-b Is a Negative Regulator of Inflammatory Cytokines Produced by IgE-Activated Mast Cells
J. Immunol., November 1, 2006; 177(9): 5980 - 5989.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.